ROYAL BANK OF CANADA - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 7 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,710,000
-55.5%
2,000,0000.0%0.00%
-100.0%
Q4 2022$3,843,0002,000,0000.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
683 Capital Management, LLC 2,950,000$3,038,5000.24%
Saltoro Capital, LP 250,000$243,7500.22%
LAZARD ASSET MANAGEMENT LLC 11,500,000$11,2120.02%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders